Barclays PLC Buys 102,046 Shares of Doximity, Inc. (NASDAQ:DOCS)

Barclays PLC grew its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 191.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 155,447 shares of the company's stock after buying an additional 102,046 shares during the quarter. Barclays PLC owned about 0.08% of Doximity worth $8,299,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. FMR LLC lifted its position in shares of Doximity by 37.6% during the 4th quarter. FMR LLC now owns 9,409,313 shares of the company's stock valued at $502,363,000 after acquiring an additional 2,571,580 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Doximity by 708.7% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock valued at $80,641,000 after buying an additional 1,323,634 shares in the last quarter. Invesco Ltd. increased its stake in shares of Doximity by 525.1% during the 4th quarter. Invesco Ltd. now owns 1,272,403 shares of the company's stock worth $67,934,000 after purchasing an additional 1,068,849 shares during the last quarter. Franklin Resources Inc. lifted its position in shares of Doximity by 1,178.3% in the fourth quarter. Franklin Resources Inc. now owns 1,062,211 shares of the company's stock worth $56,711,000 after buying an additional 979,113 shares during the last quarter. Finally, Lord Abbett & CO. LLC bought a new stake in Doximity during the third quarter worth approximately $29,453,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Trading Up 0.8 %

NASDAQ DOCS traded up $0.44 on Tuesday, hitting $57.13. 199,554 shares of the company were exchanged, compared to its average volume of 1,983,026. The company has a market cap of $10.66 billion, a PE ratio of 57.06, a PEG ratio of 4.10 and a beta of 1.41. The stock has a fifty day moving average of $60.30 and a 200-day moving average of $56.37. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21.

Insiders Place Their Bets

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 37.40% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on DOCS shares. Piper Sandler raised Doximity from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Truist Financial cut their price objective on Doximity from $65.00 to $58.00 and set a "hold" rating for the company in a report on Thursday, April 10th. Raymond James reissued an "outperform" rating and issued a $83.00 price target (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. KeyCorp cut their price objective on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Finally, Morgan Stanley reduced their target price on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a report on Thursday, April 24th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Doximity has a consensus rating of "Moderate Buy" and an average price target of $65.39.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.